 |
市场调查报告书
商品编码
1629591
全EXOME定序市场：按产品类型、按技术、按应用、按适应症、按最终用户、按地区Whole Exome Sequencing Market, By Product Type, By Technology, By Application, By Indication, By End User, By Geography |
||||||
2024 年全球全EXOME定序市场规模估计为 18 亿美元，预计 2031 年将达到 47.2 亿美元，2024 年至 2031 年的复合年增长率为 14.8%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2023 | 2024 年的市场规模 | 18亿美元 |
| 效能资料 | 2019 年至 2023 年 | 预测期 | 2024 年至 2031 年 |
| 预测期间 2024 年至 2031 年复合年增长率： | 14.80％ | 2031 年价值预测 | 47.2亿美元 |
全EXOME定序是一种强大的技术，可以分析基因的整个蛋白质转录区以检测致病的遗传变异。近年来，它彻底改变了临床诊断和基因研究。由于癌症研究应用的不断增加、个人化医疗的需求不断增长以及全基因组定序相对于传统定序技术的日益普及，全EXOME序市场预计将见证显着增长。
市场动态：
全球全EXOME定序市场受到慢性病盛行率上升、研究活动资金增加、全EXOME定序在药物发现的应用不断扩大以及精准医疗的推动。然而，预算限制、对熟练人力的需求以及缺乏适当的报销政策限制了市场的成长。新兴经济体、持续的技术进步和不断加强的产学研合作为市场参与者提供了机会。
本研究的主要特点
本报告对全球EXOME定序市场进行了详细分析，并提供了预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2023 年。
它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球全EXOME定序市场的主要企业根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行分析。
研究中介绍的主要企业包括 Illumina, Inc.、Thermo Fisher Scientific Inc.、BGI Genomics、Agilent Technologies, Inc.、Roche Diagnostics、QIAGEN NV、Pacific Biosciences of California, Inc.、Oxford Nanopore Technologies plc、Eurofins Scients Sci。 Ltd.、Laboratory Corporation of America Holdings 和 Novogene Corporation。
本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
全球全外EXOME定序市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球全EXOME定序市场所使用的各种策略矩阵来促进他们的决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要进展
- 监管情景
- 产品发布/核准
- PEST分析
- PORTER 分析
- 併购情景
- 产业趋势
4. 全球全EXOME定序市场（依产品类型），2019 年至 2031 年
- 装置
- 耗材
- 服务
5. 全球全EXOME定序市场（依技术划分），2019 年至 2031 年
- 合成定序
- 离子半导体定序
- 其他技术
6. 全球全EXOME定序市场（依应用划分），2019 年至 2031 年
- 药物研发
- 临床诊断
- 调查
7. 全球全EXOME定序市场（依适应症划分），2019 年至 2031 年
- 癌症
- 罕见/遗传疾病
- 感染疾病
- 心血管疾病
- 神经系统疾病
- 其他的
8. 全球全EXOME定序市场，依最终使用者划分，2019 年至 2031 年
- 医院和诊所
- 诊断实验室
- 学术研究所
- 生物製药公司
9. 全球全EXOME定序市场（按地区划分），2019 年至 2031 年
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第十章 竞争格局
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics
- Agilent Technologies, Inc.
- Roche Diagnostics
- QIAGEN NV
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- Eurofins Scientific SE
- Genomatix GmbH
- Myriad Genetics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Novogene Corporation
第 11 章 分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第 12 章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
The global whole exome sequencing market is estimated to be valued at USD 1.80 Bn in 2024 and is expected to reach USD 4.72 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1.80 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 14.80% | 2031 Value Projection: | US$ 4.72 Bn |
Whole exome sequencing is a powerful technology that allows analyzing the entire protein-coding region of genes in order to detect genetic variations responsible for diseases. It has revolutionized clinical diagnosis and genetic research in recent years. Whole exome sequencing market is expected to experience significant growth due to rising applications in cancer research, increasing demand for personalized medicine, and growing popularity of whole genome sequencing over traditional sequencing techniques.
Market Dynamics:
The global whole exome sequencing market is driven by rising incidence of chronic diseases, increased funding for research activities, growing applicability of whole exome sequencing in drug discovery, and precision medicine. However, budget constraints, requirement of skilled personnel and non-availability of adequate reimbursement policies limit the market growth. The market provides opportunities for players due to emerging economies, continuous technological advancements, and increasing collaborations between industry and academia.
Key Features of the Study:
This report provides in-depth analysis of the global whole exome sequencing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global whole exome sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics, Agilent Technologies, Inc., Roche Diagnostics, QIAGEN N.V., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, Eurofins Scientific SE, Genomatix GmbH, Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, and Novogene Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global whole exome sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global whole exome sequencing market
Market Segmentation
- By Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Instruments
- Consumables
- Services
- By Technology Insights (Revenue, USD Bn, 2019 - 2031)
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Other Technologies
- By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Drug Discovery & Development
- Clinical Diagnostics
- Research
- By Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Cancer
- Rare/Inherited Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals & Clinics
- Diagnostics Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics
- Agilent Technologies, Inc.
- Roche Diagnostics
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- Eurofins Scientific SE
- Genomatix GmbH
- Myriad Genetics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Novogene Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Whole Exome Sequencing Market, By Product Type
- Global Whole Exome Sequencing Market, By Technology
- Global Whole Exome Sequencing Market, By Application
- Global Whole Exome Sequencing Market, By Indication
- Global Whole Exome Sequencing Market, By End User
- Global Whole Exome Sequencing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Whole Exome Sequencing Market, By Product Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Whole Exome Sequencing Market, By Technology, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Sequencing by Synthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ion Semiconductor Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Whole Exome Sequencing Market, By Application, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Whole Exome Sequencing Market, By Indication, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rare/Inherited Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Whole Exome Sequencing Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diagnostics Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Whole Exome Sequencing Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Roche Diagnostics
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- Eurofins Scientific SE
- Genomatix GmbH
- Myriad Genetics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Novogene Corporation
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
全EXOME定序市场规模、份额和成长分析（按产品、技术、工作流程、应用、最终用途和地区）- 产业预测 2025-2032
全基因组和外显子定序市场 - 全球产业规模、份额、趋势、机会和预测，按产品、工作流程、应用、最终用户、地区和竞争细分，2019-2029F
全EXOME定序市场规模、份额、趋势分析报告：按产品、按技术、按工作流程、按应用、按最终用途、按地区、细分市场预测，2025-2030 年
全球全基因组和EXOME定序市场：按产品、工作流程、应用、最终用户、地区、竞争格局 - 分析和预测（2024-2033）
全EXOME定序市场报告：2030 年趋势、预测与竞争分析
全球全外显子定序市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测
全基因及EXOME定序的全球市场:各用途，生物，各产品，附执行顾问指南 - D2C分析(2024年～2028年)
2024 年全基因组和EXOME定序全球市场报告
2024 年全EXOME定序全球市场报告
全外显子组测序的全球市场